Vanessa A. Eulo

Vanessa A. Eulo, MD

Began fellowship in 2018

Graduated in 2021


Initial post-graduate position:

Assistant Professor, University of Alabama, Birmingham, AL


2001-2005 BSN, Boston College, ​Chestnut Hill, MA
2008-2011 Post-Baccalaureate Prehealth Professional Certificate, Northwestern University, ​Chicago, IL
2011-2015 MD, Rush Medical College, ​Chicago, IL
Post-graduate Training
2015-2018 Residency, Barnes-Jewish Hospital, St. Louis, MO
Work Experience
2005-2008 Registered nurse, New York University Medical Center, ​New York, NY
2008-2012 Float nurse, Rush University Medical Center, ​Chicago, IL
Honors & Awards
2014 Alpha Omega Alpha Honor Society
2015 Rush University Medical Center Medical Staff Prize for Clinical Excellence
2016 Inpatient Intern of the Month, January, Barnes Jewish Hospital/Washington University School of Medicine, St. Louis, MO
2018 Inpatient Resident of the Month, March, Barnes Jewish Hospital/Washington University School of Medicine, St. Louis, MO


  • A Phase II Study of Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft-Tissue Sarcomas Who Are Not Candidates for Chemotherapy
    Hirbe AC, Eulo V, Moon CI, Luo J, Myles S, Seetharam M, Toeniskoetter J, Kershner T, Haarberg S, Agulnik M, Monga V, Milhem M, Parkes A, Robinson S, Okuno S, Attia S, Van Tine BA
    Eur J Cancer 2020 Sep;137:1-9
  • Secondary Sarcomas: Biology, Presentation, and Clinical Care
    Eulo V, Lesmana H, Doyle LA, Nichols KE, Hirbe AC
    Am Soc Clin Oncol Educ Book 2020 Mar;40:1-12
  • Aberrant ATRX Protein Expression Is Associated With Poor Overall Survival in NF1-MPNST
    Lu HC, Eulo V, Apicelli AJ, Pekmezci M, Tao Y, Luo J, Hirbe AC, Dahiya S
    Oncotarget 2018 May 1;9(33):23018-23028